Faculty profile

Gary Kobinger

ResearcherMedical MicrobiologyUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.

Gary Kobinger

Researcher

Medical Microbiology

Health Sciences

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2020.
Principal investigator on 2 research grants (2 CIHR), most recently in 2015.
Supervised 3 trainees who won CIHR awards, most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

201

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Ebola Fomites Guinea Pig Transmission Model Non-Human Primate Model Pathology Reverse Genetics Transmission Virology

Latest papers

Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
Viruses · 2020 · senior author
Pulmonary Involvement during the Ebola Virus Disease.
Viruses · 2019
In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.
The Journal of infectious diseases · 2019

All 49 publications

Latest funding

Determinants of virulence and transmission in the West African Ebola outbreak
CIHR · 2015 · Nominated PI
$229,250
Characterization of a new "intracellular immunization" strategy restricting HIV-1 infection and inducing host immune response
CIHR · 2013 · Co-investigator
$100,000
A HIV Vaccine Targeting Protease Cleavage Sites
CIHR · 2013 · Co-investigator
$100,000

All 9 grants and awards

49 publications.

Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

Al-Kassmy J, Pedersen J, Kobinger G

Viruses2020Senior author

DOI: 10.3390/v12080861 PMID: 32784685

Pulmonary Involvement during the Ebola Virus Disease.

Lalle E, Biava M, Nicastri E, Colavita F, Di Caro A, Vairo F, Lanini S, Castilletti C, Langer M, Zumla A, Kobinger G, Capobianchi MR, Ippolito G

Viruses2019

DOI: 10.3390/v11090780 PMID: 31450596

In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.

Racine T, Denizot M, Pannetier D, Nguyen L, Pasquier A, Raoul H, Saluzzo JF, Kobinger G, Veas F, Herbreteau CH

The Journal of infectious diseases2019

DOI: 10.1093/infdis/jiz068 PMID: 30852585

Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry.

Qiu S, Leung A, Bo Y, Kozak RA, Anand SP, Warkentin C, Salambanga FDR, Cui J, Kobinger G, Kobasa D, Côté M

Virology2018

DOI: 10.1016/j.virol.2017.09.028 PMID: 29031163

Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections.

Robert MA, Nassoury N, Chahal PS, Venne MH, Racine T, Qiu X, Kobinger G, Kamen A, Gilbert R, Gaillet B

Human gene therapy2018

DOI: 10.1089/hum.2017.101 PMID: 29179602

Testing Experimental Therapies in a Guinea Pig Model for Hemorrhagic Fever.

Wong G, Bi Y, Kobinger G, Gao GF, Qiu X

Methods in molecular biology (Clifton, N.J.)2018

DOI: 10.1007/978-1-4939-6981-4_21 PMID: 28986842

Clinical Evaluation of Ebola Virus Disease Therapeutics.

Liu G, Wong G, Su S, Bi Y, Plummer F, Gao GF, Kobinger G, Qiu X

Trends in molecular medicine2017

DOI: 10.1016/j.molmed.2017.07.002 PMID: 28822631

Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time.

Wei H, Audet J, Wong G, He S, Huang X, Cutts T, Theriault S, Xu B, Kobinger G, Qiu X

Scientific reports2017

DOI: 10.1038/s41598-017-03318-3 PMID: 28611428

Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.

Kroeker A, Griffin BD, Qiu X, Kobinger G

Methods in molecular biology (Clifton, N.J.)2017Senior author

DOI: 10.1007/978-1-4939-7116-9_22 PMID: 28573628

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

de Wit E, Rosenke K, Fischer RJ, Marzi A, Prescott J, Bushmaker T, van Doremalen N, Emery SL, Falzarano D, Feldmann F, Groseth A, Hoenen T, Juma B, McNally KL, Ochieng M, Omballa V, Onyango CO, Owuor C, Rowe T, Safronetz D, Self J, Williamson BN, Zemtsova G, Grolla A, Kobinger G, Rayfield M, Ströher U, Strong JE, Best SM, Ebihara H, Zoon KC, Nichol ST, Nyenswah TG, Bolay FK, Massaquoi M, Feldmann H, Fields B

The Journal of infectious diseases2016

DOI: 10.1093/infdis/jiw216 PMID: 27333914

Determinants of virulence and transmission in the West African Ebola outbreak

Nominated PICIHR2015Operating Grant - Innovative Ebola Research Grants

Principal investigators: Kobinger, Gary P

Keywords: Ebola; Fomites; Guinea Pig Transmission Model; Non-Human Primate Model; Pathology; Reverse Genetics; Transmission; Virology

$229,250

Characterization of a new "intracellular immunization" strategy restricting HIV-1 infection and inducing host immune response

Co-investigatorCIHR2013Operating Grant - PA: Bridge Funding -CHVI Vaccine Discovery and Social Research

Principal investigators: Yao, Xiao-Jian

Keywords: Apobec3g; Gene Therapy; Hiv Mucosal Infection; Hiv Prevention; Host Antiviral Protein; Humanized Mouse Model; Immune Response; Intracellular Immunization

$100,000

A HIV Vaccine Targeting Protease Cleavage Sites

Co-investigatorCIHR2013Operating Grant - PA: Bridge Funding -CHVI Vaccine Discovery and Social Research

Principal investigators: Luo, Ma

Keywords: A Hiv Vaccine Tarting Protease Cleavage Sites; Low Dose Vaginal Sivmac251 Challenge; Mice And Guinea Pigs; Nanodelivery Of Immunogens; Nonhuman Primate And Sivmac239/251 Model; Vesicular Stomatitis Virus (Vsv) Vector System

$100,000

Persistent infection and restimulation of Ebolavirus from dormancy in African fruit bats

SupervisorCIHR2012Canada Graduate Scholarships - Michael Smith Foreign Study Supplements

Principal investigators: Wong, Gary C

Keywords: Bacterial Infection; Ebolavirus; Ecology; Epidemiology; Pathogens; Public Health Strategy

$6,000

A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study

Nominated PICIHR2011Operating Grant

Principal investigators: Kobinger, Gary P

Keywords: Adaptive Immune Response; Dna-Based Vaccine; Electroporation; Elispot; Hemagglutination Inhibition; Influenza Virus; Phase I Safety Trial; T And B Cells

$318,945

ATTACKING HIV PROTEASE CLEAVAGE SITES WITH IMMUNIZATION - Explore the rapid mutation rate of HIV-1

Co-investigatorCIHR2009Vaccines of the 21st Century

Principal investigators: Luo, Ma

Keywords: Hiv Protease Cleavage Sites; Hiv Vaccine Strategy; Mucosal Immunization; Nanodelivery; Vesicular Stomatitis Virus (Vsv) Vector

$100,000

Second Annual Spring Prairie Infectious Immunology Retreat

Co-investigatorCIHR2009Planning Grants - Priority Announcement: Infection and Immunity

Principal investigators: Fowke, Keith R; Bretscher, Peter A; Uzonna, Jude E

Keywords: Collaboration; Hiv Vaccine; Immunology; Infectious Diseases; Networking

$10,000

Development and evaluation of a recombinant porcine adenovirus vaccine for post-exposure protection against Ebolavirus

SupervisorCIHR2009Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Wong, Gary C

Keywords: Adaptive Immune Response; Animal Models; Ebolavirus; Human; Innate; Level Iv Biocontainment; Porcine Adenovirus; Post-Exposure Protection; Pre-Existing Immunity; Recombinant Viruses; Reverse Genetics; Vaccine Design

$105,000

Identification of virulence determinants of the 1918 Spanish Flu Hemagglutinin (HA)and its role in pathogenesis

SupervisorCIHR2008Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Silaghi, Dan A

Keywords: Animal Models; Antivirals; Cellular Activation; Epidemiological Survey; Hemagglutinin; Influenza Pandemic; Level 4 Bio-Containment; Pathogenesis; Reverse Genetics; Spanish Flu

$105,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Gary Kobinger

Research

Latest papers

Latest funding

Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

Pulmonary Involvement during the Ebola Virus Disease.

In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.

Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry.

Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections.

Testing Experimental Therapies in a Guinea Pig Model for Hemorrhagic Fever.

Clinical Evaluation of Ebola Virus Disease Therapeutics.

Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time.

Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

Determinants of virulence and transmission in the West African Ebola outbreak

Characterization of a new "intracellular immunization" strategy restricting HIV-1 infection and inducing host immune response

A HIV Vaccine Targeting Protease Cleavage Sites

Persistent infection and restimulation of Ebolavirus from dormancy in African fruit bats

A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study

ATTACKING HIV PROTEASE CLEAVAGE SITES WITH IMMUNIZATION - Explore the rapid mutation rate of HIV-1

Second Annual Spring Prairie Infectious Immunology Retreat

Development and evaluation of a recombinant porcine adenovirus vaccine for post-exposure protection against Ebolavirus

Identification of virulence determinants of the 1918 Spanish Flu Hemagglutinin (HA)and its role in pathogenesis

Frequent collaborators

Gary Kobinger

Darwyn Kobasa

Keith Fowke

Steven Theriault

James Strong

Amine Kamen

Zhou Xing

Maziar Divangahi

Kevin Coombs

Bruno Gaillet

Xiangguo Qiu